| http://www.w3.org/ns/prov#value | - The GAO testimony on medical devices will be a part of the hearing's broader effort to highlight an issue that has turned up in reports and critiques over the past few years: concerns the FDA's resources and technology are not enough to meet its regulatory responsibilities to oversee drugs, food and other products.BGS
|
